Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee hands down positive opinion on Trulicity

Sep. 29, 2014

EMA committee recommends approval of Moventig

Sep. 29, 2014

EMA recommends ketoconazole for approval in Cushing's syndrome

Sep. 29, 2014

CHMP recommends approval of aclidinium bromide/formoterol fumarate

Sep. 29, 2014

Oxabact awarded E.U. orphan drug designation for short bowel syndrome

Sep. 25, 2014

EMA approves pediatric investigation plan for TiGenix's Cx-601

Sep. 9, 2014

European orphan drug designations for CER-001 in apoA-I and ABCA1 deficiencies

Sep. 3, 2014

ALN-AT3 receives orphan drug designations in the E.U.

Aug. 8, 2014

NeuroDerm's ND-0612H eligible for EMA's centralized procedure

Aug. 7, 2014

U.S. and E.U. orphan drug designations for AbbVie's ABT-414 for glioblastoma multiforme

Aug. 5, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...